Data Quality: Drug Discovery AI’s Indispensable Foundation

Reliable discovery insights depend on models grounded in curated, verifiable scientific knowledge

1

Pharmaceutical companies are increasingly investing in AI, as evidenced by partnerships like Novo Nordisk with OpenAI and Merck with Google Cloud.
2

The quality of data used in AI models is crucial for reliable outputs in drug discovery, as messy data can lead to incorrect conclusions.
3

Curated datasets improve AI prediction accuracy, as demonstrated by Isomorphic Labs, which achieved better results with a curated data infrastructure.
4

Efficient AI in drug discovery leads to fewer false leads, quicker validation, and more confident decision-making when the data foundation is strong.
5

The success of AI in drug discovery depends on the curation and structuring of data, rather than solely on the power of the AI models themselves.

1